Dearen Danny L. 4
4 · Axonics, Inc. · Filed Apr 24, 2023
Insider Transaction Report
Form 4
Axonics, Inc.AXNX
Dearen Danny L.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-04-20$14.19/sh+2,001$28,394→ 25,994 total - Sale
Common Stock
2023-04-20$60.01/sh−2,001$120,073→ 23,993 total - Exercise/Conversion
Stock Options (Right to buy)
2023-04-20−2,001→ 13,208 totalExercise: $14.19Exp: 2029-01-30→ Common Stock (2,001 underlying)
Footnotes (3)
- [F1]This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $60.00 to $60.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date.